GT Biopharma, Inc.
GTBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000109657
No open-market purchases or sales by GT Biopharma, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $1.02M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in GT Biopharma, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- −3 vs. Q2 2023
- Shares held
- 3.44M
- +113.9K (+3.4%) vs. Q2 2023
- Total value
- $849.9K
- −$263.4K (−23.7%) vs. Q2 2023
- New holders
- 2
- 9 more added
- Sold out
- 5
- 9 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GTBP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 59 | $1.02M |
| Q1 2026 | 42 | $656.7K |
| Q4 2025 | 38 | $373.7K |
| Q3 2025 | 21 | $222.2K |
| Q2 2025 | 21 | $711.3K |
| Q1 2025 | 20 | $220.5K |
| Q4 2024 | 19 | $279.1K |
| Q3 2024 | 16 | $203.8K |
| Q2 2024 | 17 | $296.8K |
| Q1 2024 | 17 | $348.6K |
| Q4 2023 | 34 | $893.1K |
| Q3 2023 | 33 | $849.9K |
| Q2 2023 | 37 | $1.11M |
| Q1 2023 | 36 | $3.05M |
| Q4 2022 | 36 | $5.62M |
| Q3 2022 | 35 | $4.36M |
| Q2 2022 | 48 | $9.28M |
| Q1 2022 | 58 | $12.9M |
| Q4 2021 | 55 | $16.7M |
| Q3 2021 | 54 | $32.1M |
| Q2 2021 | 50 | $69.9M |
| Q1 2021 | 21 | $3.98M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding GT Biopharma, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,087,234 | $262.1K | 0.00% | −12,120−1.1% | Reduced |
| Bank of Montreal | 596,240 | $166.9K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 337,315 | $81.4K | 0.00% | +113,871+51.0% | Added |
| BlackRock Inc. | 304,041 | $73.3K | 0.00% | −763−0.3% | Reduced |
| Wells Fargo & Company | 300,697 | $72.5K | 0.00% | +200,103+198.9% | Added |
| Baskin Financial Services Inc. | 151,354 | $36.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 95,239 | $23.0K | 0.00% | 00.0% | Unchanged |
| Atria Wealth Solutions, Inc. | 88,720 | $21.4K | 0.00% | +20,000+29.1% | Added |
| Millennium Management LLC | 88,009 | $21.2K | 0.00% | −146,848−62.5% | Reduced |
| State Street Corp | 79,976 | $19.3K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 66,700 | $16.0K | 0.00% | −25,481−27.6% | Reduced |
| Compagnie Lombard Odier SCmA | 50,000 | $12.1K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 32,347 | $7.80K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 30,959 | $7.46K | 0.00% | +30,959 | New |
| Sigma Planning Corp | 20,395 | $4.92K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 20,158 | $4.86K | 0.00% | +335+1.7% | Added |
| Moss Adams Wealth Advisors LLC | 20,000 | $4.82K | 0.00% | +10,000+100.0% | Added |
| Susquehanna International Group, LLP | 13,943 | $3.36K | 0.00% | −7,311−34.4% | Reduced |
| Goldman Sachs Group Inc | 10,424 | $2.51K | 0.00% | −76−0.7% | Reduced |
| Welch Group, LLC | 10,000 | $2.41K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 8,750 | $2.11K | 0.00% | +5,717+188.5% | Added |
| Commonwealth Equity Services, LLC | 10,110 | $2.00K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 8,078 | $1.95K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,270 | $305 | 0.00% | +253+24.9% | Added |
| Bank of America Corp | 508 | $122 | 0.00% | +507+50,700.0% | Added |
| Blue Bell Private Wealth Management, LLC | 300 | $72 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 150 | $36 | 0.00% | −22,880−99.3% | Reduced |
| JPMorgan Chase & Co | 59 | $14 | 0.00% | −2,538−97.7% | Reduced |
| Front Row Advisors LLC | 58 | $14 | 0.00% | 00.0% | Unchanged |
| Retirement Group, LLC | 44 | $11 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2,436 | $0 | 0.00% | −1,383−36.2% | Reduced |
| Simplex Trading, LLC | 454 | $0 | 0.00% | +54+13.5% | Added |
| Qube Research & Technologies Ltd | 2 | $0 | 0.00% | +2 | New |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −20,501−100.0% | Sold out |
| McCollum Christoferson Group LLC | 0 | $0 | 0.00% | −17,500−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −10,458−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Coastal Capital Group, Inc. | – | – | – | – | Not filed |